Atlas Trials

Patient Acceptable Symptomatic State and Minimal Clinically Important Difference of the Fatigue in Multiple Sclerosis (SeDiF_SEP)

Clinical trial NCT03662347 · UNKNOWN

Trial details

NCT number
NCT03662347
Sponsor
Central Hospital, Nancy, France
Status
UNKNOWN
Study type
OBSERVATIONAL
Multiple Sclerosis
Start date
2020-03-19
Primary completion
2022-03-01
Enrollment
2100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.